4
Changes in Ownership
Vericel Corp Filed Acc 0001140361-26-042462
Director sold 5,500 shares at an average $49.12 ($270,175)
- Director acquired 5,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ZERBE ROBERT L MD Director | 2026-11-04 | Option exercise 10b5-1 | +2,500 | $13.05 | $32,625 | 35,495 | D |
| ZERBE ROBERT L MD Director | 2026-11-04 | Sale 10b5-1 | −2,500 | $45.40 | $113,500 | 32,995 | D |
| ZERBE ROBERT L MD Director | 2026-11-05 | Option exercise 10b5-1 | +500 | $13.05 | $6,525 | 33,495 | D |
| ZERBE ROBERT L MD Director | 2026-11-05 | Sale 10b5-1 | −500 | $55.00 | $27,500 | 32,995 | D |
| ZERBE ROBERT L MD Director | 2026-11-05 | Option exercise 10b5-1 | +2,500 | $13.05 | $32,625 | 35,495 | D |
| ZERBE ROBERT L MD Director | 2026-11-05 | Sale 10b5-1 | −2,500 | $51.67 | $129,175 | 32,995 | D |
| Derivatives | |||||||
| ZERBE ROBERT L MD Director | 2026-11-04 | Option exercise · Stock Option (Right to Buy) 10b5-1 | +2,500 | 5,000 | D | ||
| ZERBE ROBERT L MD Director | 2026-11-05 | Option exercise · Stock Option (Right to Buy) 10b5-1 | +500 | 4,500 | D | ||
| ZERBE ROBERT L MD Director | 2026-11-05 | Option exercise · Stock Option (Right to Buy) 10b5-1 | +2,500 | 2,000 | D | ||
| Open-market sales · 5,500 sh · avg $49.12 · $270,175 | |||||||
Loading xslF345X06/form4.xml…